Atlas Arteria Valuation
| MAQAF Stock | USD 3.45 0.72 26.37% |
At this time, the firm appears to be overvalued. Atlas Arteria Limited shows a prevailing Real Value of $3.12 per share. The current price of the firm is $3.45. Our model approximates the value of Atlas Arteria Limited from analyzing the firm fundamentals such as Return On Equity of 0.0695, profit margin of 2.33 %, and Current Valuation of 7.66 B as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Atlas Arteria's price fluctuation is risky at this time. Calculation of the real value of Atlas Arteria Limited is based on 3 months time horizon. Increasing Atlas Arteria's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Atlas pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Atlas Arteria Limited. Since Atlas Arteria is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Atlas Pink Sheet. However, Atlas Arteria's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.45 | Real 3.12 | Hype 3.45 | Naive 3.88 |
The real value of Atlas Pink Sheet, also known as its intrinsic value, is the underlying worth of Atlas Arteria Limited Company, which is reflected in its stock price. It is based on Atlas Arteria's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Atlas Arteria's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Atlas Arteria Limited helps investors to forecast how Atlas pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Atlas Arteria more accurately as focusing exclusively on Atlas Arteria's fundamentals will not take into account other important factors: Atlas Arteria Total Value Analysis
Atlas Arteria Limited is now forecasted to have takeover price of 7.66 B with market capitalization of 6.91 B, debt of 1.53 B, and cash on hands of 196.75 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Atlas Arteria fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
7.66 B | 6.91 B | 1.53 B | 196.75 M |
Atlas Arteria Investor Information
About 18.0% of the company outstanding shares are owned by corporate insiders. The book value of Atlas Arteria was now reported as 3.54. The company last dividend was issued on the 22nd of September 2022. Atlas Arteria Limited had 1009:1000 split on the 15th of September 2017. Based on the key measurements obtained from Atlas Arteria's financial statements, Atlas Arteria Limited is not in a good financial situation at this time. It has a very high probability of going through financial hardship in February.Atlas Arteria Asset Utilization
The concept of asset utilization usually refers to the revenue earned for every dollar of assets a company currently reports. The current return on assets of Atlas implies not a very effective usage of assets in January.Atlas Arteria Ownership Allocation
Atlas Arteria Limited retains a total of 1.45 Billion outstanding shares. Over half of Atlas Arteria's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Note that regardless of who owns the company, if the true value of the entity is less than the market is willing to pay for it, you may not be able to generate positive returns over time.Atlas Arteria Profitability Analysis
The company reported the revenue of 99.53 M. Net Income was 163.7 M with profit before overhead, payroll, taxes, and interest of 368.66 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Atlas Arteria's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Atlas Arteria and how it compares across the competition.
About Atlas Arteria Valuation
The pink sheet valuation mechanism determines Atlas Arteria's current worth on a weekly basis. Our valuation model uses a comparative analysis of Atlas Arteria. We calculate exposure to Atlas Arteria's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Atlas Arteria's related companies.Atlas Arteria Limited owns, develops, and operates toll roads. Atlas Arteria Limited was incorporated in 2009 and is based in Melbourne, Australia. Macquarie Atlas operates under Infrastructure Operations classification in the United States and is traded on OTC Exchange.
8 Steps to conduct Atlas Arteria's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Atlas Arteria's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Atlas Arteria's valuation analysis, follow these 8 steps:- Gather financial information: Obtain Atlas Arteria's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Atlas Arteria's revenue streams: Identify Atlas Arteria's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Atlas Arteria's industry and market trends, including the size of the market, growth rate, and competition.
- Establish Atlas Arteria's growth potential: Evaluate Atlas Arteria's management, business model, and growth potential.
- Determine Atlas Arteria's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Atlas Arteria's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Atlas Arteria Growth Indicators
Investing in growth stocks can be very risky. If the company such as Atlas Arteria does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 1 B | |
| Quarterly Earnings Growth Y O Y | 1.558 | |
| Forward Price Earnings | 32.6797 | |
| Retained Earnings | -439.1 M |
Complementary Tools for Atlas Pink Sheet analysis
When running Atlas Arteria's price analysis, check to measure Atlas Arteria's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Atlas Arteria is operating at the current time. Most of Atlas Arteria's value examination focuses on studying past and present price action to predict the probability of Atlas Arteria's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Atlas Arteria's price. Additionally, you may evaluate how the addition of Atlas Arteria to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |